By delivering engineered adeno-associated viruses through the brain's fluid transport network to target glial cells, scientists demonstrated a strategy that could bypass the blood-brain barrier and enable future brain-directed gene therapies. The post Engineered AAVs Harness Glymphatic System to Reach Brain Targets in Mice appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Pluripotent stem cell trial for Huntington’s disease
Jascayd gains UK licence for treatment of pulmonary...
Teva submits FDA application for paediatric Tourette...
Medical-Commercial alignment in rare disease launches:...
Top 10 Best-Selling Drugs 2026
Virtual Cells Go Multiscale to Predict Complex Biology
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.